Studies in a variety of tumor types have shown that CCR7 present on the tumor cells mediates their migration toward CCL21-expressing initial lymphatics (in preference to blood vessels) and/or LNs, thereby promoting spread via the lymphogenous route (145) [recently reviewed in (11, 26)]. This evidence concerns the gene CCL21 and neoplasm.